| 000 | 01611 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513104538.0 | ||
| 264 | 0 | _c19961028 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0918-6158 | ||
| 024 | 7 |
_a10.1248/bpb.19.444 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOdani, A | |
| 245 | 0 | 0 |
_aPopulation pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model. _h[electronic resource] |
| 260 |
_bBiological & pharmaceutical bulletin _cMar 1996 |
||
| 300 |
_a444-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAnticonvulsants _xblood |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEpilepsy _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aJapan _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aPhenytoin _xblood |
| 650 | 0 | 4 | _aPopulation |
| 650 | 0 | 4 | _aStatistics as Topic |
| 700 | 1 | _aHashimoto, Y | |
| 700 | 1 | _aTakayanagi, K | |
| 700 | 1 | _aOtsuki, Y | |
| 700 | 1 | _aKoue, T | |
| 700 | 1 | _aTakano, M | |
| 700 | 1 | _aYasuhara, M | |
| 700 | 1 | _aHattori, H | |
| 700 | 1 | _aFurusho, K | |
| 700 | 1 | _aInui, K | |
| 773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 19 _gno. 3 _gp. 444-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.19.444 _zAvailable from publisher's website |
| 999 |
_c8917343 _d8917343 |
||